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Introduction
The increasing incidence of heart failure has created
a greater number of patients with left ventricular
(LV) dysfunction who undergo coronary artery
bypass grafting (CABG) surgery.1,2 Compared with
continued medical treatment, CABG is reported to
give better long-term survival expectancies in this
group of patients.3–5 However, LV dysfunction is
reported to be the predictor of mortality in CABG.
Surgical revascularization has been shown to carry
a high perioperative mortality and morbidity in
patients with LV dysfunction.3,6,7 On the other
hand, with recent improvements in anesthesia,
surgical technique, myocardial protection, and
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perioperative support, CABG could be done in
these patients with acceptable safety.8–11 It could
also be an alternative for heart transplantation for
these high-risk patients.8,12,13
Because of economic development and change in
lifestyle, coronary artery disease has become one of the
leading causes of mortality in Taiwan. We have
previously reported our experiences with the outcome
of CABG,14,15 but the portion of experiences in patients
with LV dysfunction remains unknown. The purpose
of this study was to evaluate the results of CABG in
these high-risk patients. In this study, we hope to
provide information about indication of CABG in
patients with LV dysfunction and improve the quality
of patient care.
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Methods
A total of 3,308 patients underwent CABG surgery in
Taipei Veterans General Hospital from January 1,
1991 to December 31, 2002. Seventy of the patients
underwent repeat CABG. In addition to CABG,
associated procedures were done in 401 patients,
including repair of LV aneurysm, mitral valve repair,
mitral valve replacement, aortic valve replacement,
repair of ventricular septum rupture after myocardial
infarction (MI), carotid endarterectomy, repair of
abdominal aortic aneurysm, repair of ascending or
descending thoracic aortic aneurysm, bypass surgery
for peripheral arterial occlusive disease, and resection
of myxoma. Excluding patients with repeat CABG and
associated procedures, 2,842 patients had primary,
isolated CABG during the 12-year study period.
The LV function was evaluated by LV ejection
fraction (LVEF), which was determined by multigated
equilibrium radionuclide angiography. The medical
records of 1,847, among 2,842 patients who had
preoperative LVEF examinations, were reviewed
retrospectively. Eighteen variables (Table 1) and 7
operative variables (Table 2) were analyzed and
compared between patients with LVEF < 35% and
patients with LVEF * 35%. The severity of angina was
graded from 1 to 4 as defined by the Canadian
Cardiovascular Society.16 The severity of symptoms of
congestive heart failure was categorized into 1 of 4
levels, depending on exercise limitations according to
New York Heart Association (NYHA) function
classification. Smoking 1 pack or more of cigarettes
per day up to the time of surgery was considered a
contributing factor for congestive heart failure.
Table 1. Clinical variables of patients with or without LVEF < 35%
LVEF < 35% Percentage (%) LVEF * 35% Percentage (%) p
Number 365 19.8 1,482 80.2
Age 38–86 39–86
Mean 67.9 ± 7.4 67.5 ± 7.9 0.362
Sex 0.677
Male 336 92.1 1,352 91.2
Female 29 7.9 130 8.8
Angina class 0.000
Class 1 51 14.0 148 10.0
Class 2 166 45.5 851 57.4
Class 3 123 33.7 442 29.8
Class 4 25 6.8 41 2.8
NYHA class 0.000
Class 1 154 42.2 983 66.3
Class 2 105 28.8 401 27.1
Class 3 61 16.7 72 4.9
Class 4 45 12.3 26 1.8
Smoking 173 47.4 733 49.5 0.484
Hypertension 228 62.5 1,015 68.5 0.029
Diabetes 142 38.9 486 32.8 0.031
Cholesterol > 250 mg/dL 101 27.7 497 33.5 0.034
History of MI 210 57.5 428 28.9 0.000
History of CHF 66 18.1 48 3.2 0.000
Creatinine > 2.0 mg/dL 48 13.2 120 8.1 0.004
COPD 26 7.1 71 4.8 0.088
History of CVA 31 8.5 112 7.6 0.584
PAOD 39 10.7 102 6.9 0.020
LV aneurysm 22 6.0 15 1.0 0.000
History of PTCA 64 17.5 273 18.4 0.762
LVEF
Mean 27 ± 5.0 50.5 ± 8.7 0.000
CHF = congestive heart failure; COPD = chronic obstructive pulmonary disease; CVA = cerebrovascular accident; LVEF = left ventricular ejection fraction;
MI = myocardial infarction; PAOD = peripheral arterial occlusive disease; PTCA = percutaneous transluminal coronary angioplasty.
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Hypertension was considered a condition requiring
antihypertensives. Clinical diabetes mellitus was
considered a condition requiring insulin or oral
antidiabetics.17 A history of MI was recorded if the
patient had been informed by a physician of a definite
infarction or if the patient’s electrocardiogram
revealed an old infarction prior to surgery. Peripheral
arterial occlusive disease was documented by a
combination of ischemic symptoms and diminished
pulses in the lower limb, or by history of a previous
construction procedure for peripheral arterial
occlusive disease.17
Operative variables included priority of procedures,
presence or absence of the left main coronary artery
lesion, number of coronary arteries involved, number
of anastomoses, cardiopulmonary bypass time, aortic
cross-clamping time, and use of arterial grafts (Table
2). Definition of the operation as elective or emergent
was determined by the operating surgeons, but
emergent procedures generally included those
performed less than 24 hours after coronary
angiography or during a clearly deteriorating clinical
condition.18 The left main lesion was considered present
when the extent of luminal narrowing of the left main
coronary artery was 50% or greater. The number of
seriously stenosed coronary arteries was defined
according to the number of coronary arteries with
luminal narrowing of 70% or more.19
The surgical techniques have been described
in previous reports.14,15 All operations used
cardiopulmonary bypass with moderate hemodilution
(hematocrit, 20–25%) and moderate systemic
hypothermia (25–28°C). Ascending aortic and
2-stage, single-venous cannulation was employed.
Myocardial preservation was generally achieved with
intermittent, multidose, cold-crystalloid cardioplegia.
Crystalloid cardioplegia was infused through the aortic
root at least every 20 minutes, and was then additionally
infused into each completed vein graft. Blood
cardioplegia was usually used for patients with LV
hypertrophy, cardiogenic shock, or acutely occluded
coronary arteries. Distal coronary anastomoses were
performed first in the arrested heart with aortic root
venting. Aortic anastomoses were done over a partial
clamp in the beating, nonloading heart.
Statistical analysis
All data were expressed as means ± standard deviation
or percentages where appropriate. Discrete variables
were analyzed with Chi-square test, and continuous
variables were analyzed by unpaired Student’s t test.
A p value less than 0.05 was considered statistically
significant.
Results
From January 1, 1991 to December 31, 2002, 1,847
patients underwent primary isolated CABG. A total
of 365 patients (19.8%) had LVEF < 35%, while
1,482 patients (80.2%) had LVEF * 35% (Table 1).
There was no significant difference in the mean
age or sex distribution. The prevalence of smoking as
a risk factor also showed no significance. The
comorbidity of chronic obstructive pulmonary disease
and history of cerebrovascular accident were also the
same between both groups. Angina and NYHA class
were significantly more severe in LV dysfunction
patients. These patients also had a significantly higher
percentage of diabetes, and history of MI, congestive
heart failure, peripheral arterial occlusive disease and
LV aneurysm. Patients with LVEF * 35% had a
Table 2. Operative variables of patients with or without LVEF < 35%
LVEF < 35% Percentage (%) LVEF * 35% Percentage (%) p
Emergent operation 24 6.6 86 5.8 0.621
LMCA lesion 63 17.3 315 21.3 0.096
Diseased vessel number 0.055
Single 14 3.8 89 6.0
Double 58 15.9 289 19.5
Triple 293 80.3 1,104 74.5
Anastomosis number 3.4 ± 1.0 3.3 ± 1.1 0.006
Ischemic time (min) 87 ± 735 86 ± 733 0.694
CPB time (min) 147 ± 44 137 ± 40 0.000
LIMA graft 171 46.8 974 65.7 0.000
CPB = cardiopulmonary bypass; LIMA = left internal mammary artery; LMCA = left main coronary artery; LVEF = left ventricular ejection fraction.
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significantly higher percentage of hypertension and
cholesterol levels greater than 250 mg/dL. There
was no significant difference in the history of
percutaneous transluminal coronary angioplasty
between the 2 groups (Table 1).
There was no significant difference in the percentage
of emergent operation, left main coronary artery lesion,
number of stenotic coronary artery vessels, and aortic
cross-clamp time between the 2 groups (Table 2).
However, patients with LVEF < 35% had significantly
more grafts, anastomoses, and longer cardiopulmonary
bypass times. Significantly more left internal mammary
artery (LIMA) grafts were used in patients with LVEF
* 35% (Table 2).
Patients with LVEF < 35% had significantly higher
operative and hospital mortality (Table 3). A
significantly higher incidence of major morbidity was
also noted in patients with LV dysfunction. Patients
with LVEF < 35% had significantly longer hospital
stays.
Discussion
LV dysfunction has been identified as one of the most
significant independent predictors of operative
mortality.20,21 Christakis et al9 reported a higher
operative mortality rate (9.8%) for patients with
LVEF < 20% than those with LVEF between 20 and
40% (4.8%) and those with LVEF > 40% (2.3%).
Because of widespread application of thrombolysis
and the increase in survivors from acute MI, the
prevalence of moderate-to-severe LV dysfunction
seemed to increase in patients referred for CABG.
Endovascular therapy might also delay surgical
revascularization until coronary atherosclerosis is
more extensive and ventricular dysfunction is more
severe.22
Although mortality has shown to be high for LV
dysfunction patients undergoing CABG, Cimochowski
et al18 advocated that a combination of chemical,
metabolic, and mechanical support could reduce the
operative mortality rate to 1.8% in patients with severe
LV dysfunction who underwent isolated coronary
artery bypass grafting. Mickleborough et al10,23 also
reported lower mortality and morbidity for patients
with poor LV function (LVEF < 20%) by improved
cardioplegic techniques.
Better results have been found with surgical
treatment than medical treatment in patients with LV
dysfunction. Alderman et al3 compared medical and
surgical treatments in poor LV function patients
(LVEF < 35%). The 5-year survival rate was 63% in
surgically treated patients, compared with 43% in
medically treated patients. Although the operative
mortality was 6.9%, the authors concluded that
patients with predominantly ischemic pain symptoms,
despite poor LV function, benefit from surgery.
Table 3. Results of CABG surgery in patients with or without LVEF < 35%
Outcome LVEF < 35% Percentage (%) LVEF * 35% Percentage (%) p
Operative mortality (< 30 days) 13 3.6 18 1.2 0.005
Hospital mortality 24 6.6 33 2.2 0.000
Major morbidity 85 23.3 238 16.1 0.002
Lower limb wound infection 20 5.5 76 5.1
Postoperative heart failure 12 3.3 12 0.8
Respiratory failure 11 3.0 25 1.7
Postoperative VT 10 2.7 28 1.9
Perioperative MI 6 1.6 20 1.3
Stroke 6 1.6 17 1.1
Renal failure 6 1.6 16 1.1
Mediastinitis 5 1.4 13 0.9
GI bleeding 4 1.1 12 0.8
Sternal dehiscence 3 0.8 11 0.7
Go-in for bleeding 3 0.8 16 1.1
UTI 2 0.5 6 0.4
Phrenic nerve palsy 0 0.0 3 0.2
Hospital stay (days) 25 ±  23 21 ±  16 0.001
CABG = coronary artery bypass grafting; GI = gastro-intestinal; MI = myocardial infarction; UTI = urinary tract infection; VT = ventricular
tachycardia.
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In the current study, patients with LV dysfunction
were found to have a higher degree of angina and
NYHA class, significantly higher percentage of diabetes,
and history of MI, congestive heart failure, peripheral
arterial occlusive disease, and LV aneurysm (Table 1).
Christakis et al9 reported that patients with LV
dysfunction were older, predominantly male, had a
higher percentage of left main stenosis, and more
frequently required urgent surgery for unstable angina.
Yau et al22 demonstrated a decrease in mortality with
time, despite an increasing prevalence and risk-profile
of patients with LV dysfunction.
In addition to LIMA being a patent and long-lasting
graft, it is also reported to have considerably reduced
mortality.24 Anderson et al25 demonstrated an obvious
enhancement of late survival with the use of IMA
grafting in patients with chronic congestive heart failure
over a 5-year follow-up period. However, other reports
denied its influence on the long-term survival in patients
with LV dysfunction.20,26 Because of the conflicting
results, LIMA grafting was not used routinely in the
poor LV function group in the current study.
There were several limitations in the present study.
The data for some variables were not available for all
patients because of the study’s retrospective nature.
Only 1,847 patients (65%) had preoperative LVEF
examination. The LVEF study was not universal even
for patients of emergent CABG, which may have
affected our mortality rate in those high-risk patients.
The study period covered 12 years. The strategy of the
care given in the postoperative intensive care unit and
the techniques of myocardial protection may have
improved during that period. No postoperative follow-
up was done in this study. Prospective multicenter
studies involving more patients and establishing a
predictive mortality scoring system would more
accurately assess the results of CABG in poor LV
function patients.
In conclusion, patients with severe LV dysfunction
ran a higher risk of mortality and morbidity undergoing
CABG. However, the results of CABG in these high-
risk patients were acceptable. More sophisticated
techniques in anesthesia, surgery, and postoperative
care are mandatory in patients with severe LV
dysfunction.
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